1. Jinchi Zhou#, Mengmeng Cui#, Junrong Liang, Jing Zhao*, Yanjie Guo*. ZYG11B participates in the modulation of colorectal cancer cell proliferation and immune infiltration and is a prognostic biomarker. BMC Cancer. 2024 Sep 30. DOI: 10.1186/s12885-024-12963-7. (共同通讯作者，JCR 二区top，IF=3.4)
2. Qichao Huang#,*, Dan Wu#, Jing Zhao#, Zeyu Yan, Lin Chen, Shanshan Guo, Dalin Wang, Chong Yuan, Yiping Wang, Xiaoli Liu, Jinliang Xing*. TFAM loss induces nuclear actin assembly upon mDia2 malonylation to promote liver cancer metastasis. EMBO J. 2022. DOI: 10.15252/embj.2021110324. (共同第一作者，JCR 一区，IF=14.012)
3. Jing Zhao#, Xiaohong Zhang#, Tian Gao#, Yiran Hou, Peng Yuan, Yi Yang, Tao Yang, Jinliang Xing, Jibin Li*, Shujuan Liu*. SIK2 enhances synthesis of fatty acid and cholesterol in ovarian cancer cells and tumor growth through PI3K/Akt signaling pathway. Cell Death and Disease. 2020 Jan 13;11(1):25. DOI: 10.1038/s41419-019-2221-x.（第一作者，JCR 一区，IF=8.469）
4. TianGao#, XiaohongZhang#, JingZhao#, FengZhou, YayaWang, ZhengZhao, JinliangXing, BiliangChen, JibinLi*, ShujuanLiu*. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer. Cancer letters. 2020 Jan 28;469:89-101. DOI: 10.1016/j.canlet.2019.10.029.（共同第一作者，JCR 一区，IF=8.679）.
5. Jing Zhao#, Yiran Hou#, Jing Hu, Xingchun Zhou, Xu Guo, Xiaojun Huang, Qichao Huang, Tingting Ren, Jinliang Xing, Shaogui Wan*, Jibin Li*, Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma. Oncogene. 2020 Feb;39(8):1724-1738. DOI: 10.1038/s41388-019-1093-y.（第一作者，JCR 一区，IF=9.867）.
